Literature DB >> 3335102

Salvage of infected total knee arthroplasty.

A G Rosenberg1, B Haas, R Barden, D Marquez, G C Landon, J O Galante.   

Abstract

Between 1981 and 1986, 25 patients with 26 infected total knee arthroplasties (TKAs) were treated with complete debridement of the knee, prosthetic removal, and six weeks of intravenous antibiotics, followed by insertion of a new prosthesis. The patients were followed for 12-57 months (average, 29 months). There was no evidence of residual infection at follow-up examination in any case. Applying the Hospital for Special Surgery knee rating system, 12 patients (50%) were rated excellent, six patients (25%) good, two patients (9%) fair, and four patients (6%) poor. Of the six patients with fair and poor results, five had reduced scores due to joint problems unrelated to the infected TKA. Fourteen patients had no pain at follow-up examination, and four had only slight pain. Nine patients had no limp, ten had a slight limp, one had a moderate limp, and the remainder either had a severe limp or were bedridden due to other joint problems. Eight patients could walk an unlimited distance and four could walk at least one-half mile. Twenty-one knees had a range of flexion greater than 90 degrees. Three patients had extensor lags of 20 degrees or greater. Only one patient required bracing for ambulation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3335102

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  9 in total

Review 1.  Two-stage revision of septic knee prosthesis with articulating knee spacers yields better infection eradication rate than one-stage or two-stage revision with static spacers.

Authors:  C L Romanò; L Gala; N Logoluso; D Romanò; L Drago
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2012-01-21       Impact factor: 4.342

2.  Durable infection control and function with the PROSTALAC spacer in two-stage revision for infected knee arthroplasty.

Authors:  Christopher R Gooding; Bassam A Masri; Clive P Duncan; Nelson V Greidanus; Donald S Garbuz
Journal:  Clin Orthop Relat Res       Date:  2011-04       Impact factor: 4.176

3.  Treatment based on the type of infected TKA improves infection control.

Authors:  Young-Hoo Kim; Yoowang Choi; Jun-Shik Kim
Journal:  Clin Orthop Relat Res       Date:  2011-04       Impact factor: 4.176

4.  Two-stage exchange knee arthroplasty: does resistance of the infecting organism influence the outcome?

Authors:  Mark F Kurd; Elie Ghanem; Jill Steinbrecher; Javad Parvizi
Journal:  Clin Orthop Relat Res       Date:  2010-08       Impact factor: 4.176

5.  Are cementless stems more durable than cemented stems in two-stage revisions of infected total knee arthroplasties?

Authors:  Paul K Edwards; Thomas K Fehring; William G Hamilton; Brett Perricelli; Walter B Beaver; Susan M Odum
Journal:  Clin Orthop Relat Res       Date:  2014-01       Impact factor: 4.176

6.  [Treatment of infected total knee arthroplasty. 2-5-year results following two-stage reimplantation].

Authors:  M Pietsch; C Wenisch; S Hofmann
Journal:  Orthopade       Date:  2009-04       Impact factor: 1.087

7.  Comparison of articulating and static spacers regarding infection with resistant organisms in total knee arthroplasty.

Authors:  En-Rung Chiang; Yu-Ping Su; Tain-Hsiung Chen; Fang-Yao Chiu; Wei-Ming Chen
Journal:  Acta Orthop       Date:  2011-08       Impact factor: 3.717

Review 8.  Outcome of prosthesis exchange for infected knee arthroplasty: the effect of treatment approach.

Authors:  Esa Jämsen; Ioannis Stogiannidis; Antti Malmivaara; Jorma Pajamäki; Timo Puolakka; Yrjö T Konttinen
Journal:  Acta Orthop       Date:  2009-02       Impact factor: 3.717

Review 9.  A systematic review of the evidence for single stage and two stage revision of infected knee replacement.

Authors:  James P M Masters; Nicholas A Smith; Pedro Foguet; Mike Reed; Helen Parsons; Andrew P Sprowson
Journal:  BMC Musculoskelet Disord       Date:  2013-07-29       Impact factor: 2.362

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.